tiprankstipranks
Trending News
More News >
Entrada Therapeutics Inc (TRDA)
:TRDA
US Market

Entrada Therapeutics Inc (TRDA) Cash flow

Compare
144 Followers

Entrada Therapeutics Inc Cash Flow

TRDA's free cash flow for Q3 2025 was $-28.14M. For the 2025 fiscal year, TRDA's free cash flow was decreased by $-178.90M and operating cash flow was $-28.31M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -41.56M$ 139.80M$ -93.79M$ -50.86M$ -25.57M
Investing Cash Flow
$ -27.80M$ -138.40M$ -148.65M$ -4.58M$ -2.32M
Financing Cash Flow
$ 102.96M$ 21.04M$ 479.00K$ 307.46M$ 50.09M
End Cash Position
$ 105.16M$ 71.55M$ 45.16M$ 291.06M$ 39.05M
Free Cash Flow
$ -44.72M$ 134.19M$ -96.67M$ -55.44M$ -27.89M
Currency in USD

Entrada Therapeutics Inc Cash Flow